Retrospective case review of missed opportunities for primary prevention of stroke and TIA in primary care: protocol paper

Introduction Stroke is a major health problem and transient ischaemic attack (TIA) is an important risk factor for stroke. Primary prevention of stroke and TIA will have the greatest impact on reducing the burden of these conditions. Evidence-based guidelines for stroke/TIA prevention identify individuals eligible for preventative interventions in primary care. This study will investigate: (1) the proportion of strokes/TIAs with prior missed opportunities for prevention in primary care; (2) the influence of patient characteristics on missed prevention opportunities and (3) how the proportion of missed prevention opportunities has changed over time. Methods and analysis A retrospective case review will identify first-ever stroke and patients with TIA between 2000 and 2013 using anonymised electronic medical records extracted from the health improvement network (THIN) database. Four categories of missed opportunities for stroke/TIA prevention will be sought: untreated high blood pressure in patients eligible for treatment (either blood pressure ≥160/100 or ≥140/90 mm Hg in patients at high cardiovascular disease (CVD) risk); patients with atrial fibrillation with high stroke risk and no anticoagulant therapy; no lipid modifying drug therapy prescribed in patients at high CVD risk or with familial hypercholesterolaemia. The proportion of patients with each missed opportunity and multiple missed opportunities will be calculated. Mixed effect logistic regression will model the relationship between demographic and patient characteristics and missed opportunities for care; practice will be included as a random effect. Ethics and dissemination THIN data collection was approved by the NHS South East Multi-centre Research Ethics Committee (MREC) in 2003. This study was approved by the independent scientific review committee in May 2013. Dissemination of findings has the potential to change practice, improve the quality of care provided to patients and ultimately reduce the incidence of strokes and TIAs. Findings will be published in a peer-reviewed journal and disseminated at national and international conferences.

[1]  K. Nakashima,et al.  [The Rotterdam study]. , 2011, Nihon rinsho. Japanese journal of clinical medicine.

[2]  F. Veith,et al.  Letter by Paraskevas et al regarding article, "Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American Heart Association/american Stroke Association". , 2011, Stroke.

[3]  Seemant Chaturvedi,et al.  Guidelines for the Primary Prevention of Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2011, Stroke.

[4]  B. Stegmayr,et al.  Sex Differences in Stroke Epidemiology: A Systematic Review , 2009, Stroke.

[5]  A. Maguire,et al.  The importance of defining periods of complete mortality reporting for research using automated data from primary care , 2009, Pharmacoepidemiology and drug safety.

[6]  B. Hedblad,et al.  Barriers to adherence to hypertension guidelines among GPs in southern Sweden: A survey , 2008, Scandinavian journal of primary health care.

[7]  M. Shumway,et al.  Access to Mental Health Treatment by English Language Proficiency and Race/Ethnicity , 2007, Journal of General Internal Medicine.

[8]  P. Whincup,et al.  Missed opportunities for secondary prevention of cerebrovascular disease in elderly British men from 1999 to 2005: a population-based study. , 2007, Journal of public health.

[9]  J. Robson,et al.  Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease , 2007, Heart.

[10]  Independent predictors of stroke in patients with atrial fibrillation , 2007, Neurology.

[11]  P. Owusu-Agyei,et al.  Stroke prevention: missed opportunities , 2007, The Lancet.

[12]  T. Lancet.  Stroke—prevention is better than cure , 2007, The Lancet.

[13]  K. Freund,et al.  Sources of Variation in Physician Adherence with Clinical Guidelines: Results from a Factorial Experiment , 2007, Journal of General Internal Medicine.

[14]  Child,et al.  Strategic Health Authorities in England , 2006 .

[15]  Diabetes Uk,et al.  JBS 2: Joint British Societies9 guidelines on prevention of cardiovascular disease in clinical practice , 2005 .

[16]  S. von Haehling,et al.  Statins for heart failure: at the crossroads between cholesterol reduction and pleiotropism? , 2004, Heart.

[17]  P. Touboul,et al.  Statins in Stroke Prevention and Carotid Atherosclerosis: Systematic Review and Up-to-Date Meta-Analysis , 2004, Stroke.

[18]  Melissa A. Fischer,et al.  Clinician awareness of adherence to hypertension guidelines. , 2004, The American journal of medicine.

[19]  Mark Woodward,et al.  Cholesterol, coronary heart disease, and stroke in the Asia Pacific region. , 2003, International journal of epidemiology.

[20]  N J Wald,et al.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[21]  A. Hofman,et al.  Incidence, risk, and case fatality of first ever stroke in the elderly population. The Rotterdam Study , 2003, Journal of neurology, neurosurgery, and psychiatry.

[22]  R. Collins,et al.  Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.

[23]  K. Donato,et al.  Body mass index and the prevalence of hypertension and dyslipidemia. , 2000, Obesity research.

[24]  M. Cabana,et al.  Why don't physicians follow clinical practice guidelines? A framework for improvement. , 1999, JAMA.

[25]  Mark Persoff.  UK , 1999, EC Tax Review.

[26]  D. Kromhout.  Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts , 1995, The Lancet.

[27]  T. Miettinen,et al.  Diagnosis of heterozygous familial hypercholesterolemia. DNA analysis complements clinical examination and analysis of serum lipid levels. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[29]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias , 1990, The Lancet.

[30]  N. Mantel.  Why Stepdown Procedures in Variable Selection , 1970 .

[31]  S. Allender,et al.  Coronary heart disease statistics. , 2008 .